Skip to main content
. Author manuscript; available in PMC: 2010 Nov 18.
Published in final edited form as: Mol Ther. 2005 Dec 1;13(3):517–527. doi: 10.1016/j.ymthe.2005.10.008

FIG. 1.

FIG. 1

AAV8 in cultured cells and AAV1, AAV2, AAV5, and AAV8 in rat hippocampus. (A) GFP epifluorescence in mixed neuron/astroglia culture 5 days after adding AAV8 GFP (1 × 1011 vector genomes per 1 × 105 plated cells). (B) Colocalization of GFP (green) and the neuronal marker NeuN (red) demonstrating efficient neuronal gene transfer. (C) Colocalization of GFP (green) and the astroglial marker GFAP (red) in a microscopic field containing mostly astrocytes. (D) Green fluorescence from AAV1 GFP vector. (E) AAV2 GFP. (F) AAV5 GFP. (G) AAV8 GFP. Equal dose (2 × 1010 vector genomes), equal expression interval (4 weeks), and equal exposure time for image capture in D–G (1 s) demonstrate relatively robust GFP signal with AAV8. Sections shown in D–G are proximal to the injection track, are the peak sections for each subject shown, and represent the overall trend in relative brightness observed in 10 animals/serotype group. (H–K) Same order of serotypes as D–G with DAPI counterstain and with various exposure times. Bars: A, 160 μm; B, 100 μm; D, 610 μm; H, 305 μm. B and C, D–G, and H–K same magnifications.